Crohn's & Colitis Foundation
Angela Dobes has a diverse work experience that spans various industries and roles. Angela started their career as a Pharmaceutical Validation specialist at Washington Group International (now URS Corporation) in 2004. Angela then transitioned to work as a Quality Assurance professional at ClinPhone (now PAREXEL Informatics) in 2006. In 2007, Angela joined Forest Laboratories (now Allergan) as a Research Informatics leader, where they managed software development projects, established KPIs, and acted as a change agent to drive growth. Angela also held leadership positions and managed a team of three direct reports. Angela's next role was as a member of the Shared Investigator Platform initiative at TransCelerate BioPharma Inc. in 2013-2014. In 2014, they joined the Crohn's & Colitis Foundation as the Senior Vice President of IBD Plexus, where they led the creation of a national-scale, cloud-based platform for data collaboration in inflammatory bowel diseases research. Additionally, Angela was an Official Member of the Forbes Nonprofit Council from 2017 to 2020.
Angela Dobes has a Bachelor of Science (BS) degree in Chemical Engineering from Lehigh University. Angela also holds a Master of Public Health (MPH) degree from the Icahn School of Medicine at Mount Sinai.
Crohn's & Colitis Foundation
5 followers
The Crohn's & Colitis Foundation is the leading non-profit organization focused on both research and patient support for inflammatory bowel disease (IBD). The Foundation’s mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life for the millions of Americans living with IBD. Our work is dramatically accelerating the research process through our database and investment initiatives; we also provide extensive educational resources for patients and their families, medical professionals, and the public.